- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Chemotherapy Research and Practice
Volume 2011 (2011), Article ID 602812, 6 pages
doi:10.1155/2011/602812
Bevacizumab Improves Quality of Life in Patients with Recurrent Glioblastoma
1Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA
2Advanced Medicine Center, 875 Blake Wilbur Drive, CC2221 Stanford, CA 94305, USA
3Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA
Received 18 April 2011; Revised 12 June 2011; Accepted 8 July 2011
Academic Editor: Evangelia D. Razis
Copyright © 2011 Seema Nagpal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
How to Cite this Article
Seema Nagpal, Griffith Harsh, and Lawrence Recht, “Bevacizumab Improves Quality of Life in Patients with Recurrent Glioblastoma,” Chemotherapy Research and Practice, vol. 2011, Article ID 602812, 6 pages, 2011. doi:10.1155/2011/602812